Here's why the J&J COVID-19 vaccine is no longer available in the U.S. The FDA decided to withdraw authorization for Johnson & Johnson's COVID-19 vaccine.
Safety and efficacy data of the Johnson & Johnson COVID-19 vaccine, recently published in the New England Journal of Medicine , found that a second dose of the jab offered up to 82% protection.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
“COVID-19 constantly exploits our divisions," said Matshidiso Moeti, WHO’s regional director for Africa. "We will only get the better of the virus if we work together for solutions.”
The European Medicines Agency has approved a new manufacturing site for Johnson & Johnson s COVID-19 vaccine, in a move that should boost production of the one-dose vaccine across the 27-nation EU. In a statement Friday, the EU drug regulator said the new site in Anagni, Italy, will finish manufacturing of the J&J vaccine, which was licensed for use in adults across Europe in March. Production problems have stalled J&J s roll-out across the European Union in recent months and millions of doses made at a U.S. factory had to be thrown out after contamination issues. The EU has ordered 200 million doses of the J&J vaccine and was expecting 55 million by the end of June; to date, fewer than 14 million doses have been distributed.